ArticleJournal of mood and anxiety disorders2026
Psychiatric comorbidity in DiGeorge association: Suicidal ideation and bipolar disorder.
Article in Journal of mood and anxiety disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DiGeorge syndrome, also known as 22q11.2 deletion syndrome, is a multisystem condition associated with congenital cardiac defects, craniofacial abnormalities, immune dysfunction, endocrine disturbances, and a high lifetime risk of psychiatric disorders. Bipolar I Disorder is a severe mood disorder with a substantially elevated risk of suicidal ideation and attempts, especially during manic episodes with psychotic features. This report describes a woman in her 20's with 22q11.2 Deletion Syndrome and Bipolar I Disorder who presented with acute suicidal ideation in the context of a manic episode. She responded to inpatient stabilization and responded well to valproic acid and olanzapine. This case highlights the substantial clinical impact of psychiatric illness in 22q11.2 deletion syndrome and reinforces the need for heightened attention to mood instability and suicide risk in affected individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.